Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 4, 1995, Pages 1407-1415

  Rasmussen, Michael Højby ^a   Hvidberg, Annemarie ^a   Juul, Anders ^b   Main, Katharina M ^b   Gotfredsen, Anders ^a   Skakkebaek, Niels E ^b   Hilsted, Jannik ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GROWTH HORMONE; SOMATOMEDIN C;

ABSORPTIOMETRY; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; ANTHROPOMETRY; ARGININE; CARRIER PROTEINS; CIRCADIAN RHYTHM; FEMALE; GROWTH HORMONE; HUMAN; HYPOGLYCEMIA; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; MALE; OBESITY; SOMATOMEDINS; SUPPORT, NON-U.S. GOV'T; WEIGHT LOSS;

EID: 0028953083     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.4.7536210     Document Type: Article

References (49)

1. Glass AR. 1989 Endocrine aspects of obesity. Med Clin North Am. 73:139-160.
2. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G. 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatropism of obesity in man. J Clin Endocrinol Metab. 72:51-59.
3. Williams T, Berelowitz M, Joffe SN, et al. 1984 Impaired growth hormone response to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 311:1403-1407.
4. Kelijman M, Frohman LA. 1988 Responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J Clin Endocrinol Metab. 66:489-494.
5. Tanaka K, Inoue S, Numata K, Okazaki H, Nakamura S, Takamura Y. 1990 Very low calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine and L-dopa in obesity. Metabolism. 39:892-896.
6. Kopelman PG, Pilkington TRE, White N, Jeffcoate SL. 1980 Evidence for existence of two types of massive obesity. Br Med J. 281:82-83.
7. Jung RT, Campbell RG, James WPT, Callingham BA. 1982 Altered hypothalamic and sympathetic responses to hypoglycaemia in familial obesity. Lancet. 1:1043-1046.
8. Laurian L, Oberman Z, Hoerer E, Wiznitzer T, Harell A. 1982 Growth hormone response to L-dopa in the thinned obese. Isr J Med Sci. 18:625-629.
9. Iranmanesh A, Veldhuis JD. 1992 Clinical pathophysiology of the somatotropic (GH) axis in adults. In: Veldhuis JD, ed. Endocrinology and metabolism clinics of North America. Philadelphia: Saunders; 783-816.
10. Bercu BB, Shulman D, Root AW, Spiliotis B. 1986 Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab. 63:709-716.
11. Davidson MB. 1987 Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 8:115-131.
12. Jorgensen JOL, Pedersen SA, Thuesen L, et al. 1989 Benneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1224.
13. Salomon F, Cuneo RC, Hesp R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
14. Langford KS, Miell JP. 1993 The insulin-like growth factor-I/bind-ing protein axis: physiology, pathophysiology and therapeutic manipulations. Eur J Clin Invest. 23:503-516.
15. Hussain MA, Schmitz O, Mengel A, et al. 1993. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest. 92:2249-2256.
16. Copeland KC, Colettii RB, Devlin JT, McAuliffe TL. 1990 The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism. 39:584-587.
17. Rasmussen MH, Fiystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. 1994 The impact of obesity, fat distribution and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone. Metabolism. 43:315-319.
18. National Academy of Sciences. 1979 1980 revised recommended dietary allowance. J Am Diet Assoc. 75:623-625.
19. Hey H, Petersen HD, Andersen T, Quaade F. 1986 Formula diet plus free additional food choice up to 1000 kcal (4.2 MJ) compared with an isoenergetic conventional diet in the treatment of obesity. A randomised clinical trial. Clin Nutr. 6:195-199.
20. Kowarski A, Thompson RG, Migeon CJ, Blizzard RM. 1971 Determination of integrated plasma concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab. 32:356-360.
21. Juul A, Bang P, Hertel NT, et al. 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults; relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab. 78:744-752.
22. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich J. 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
23. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1,-2,-3) decreases with age and is increased in acromegalic patients. Clin Endocrinol (Oxf). In press.
24. Jarhult J, Holst J. 1978 Reflex adrenergic control of endocrine pancreas evoked by unloading of carotid baroreceptors in cats. Acta Physiol Scand. 70:377-382.
25. Torresani T, Dinesen B. 1991 Growth hormone assay in urine: evaluation of a commercial kit. In: Cavallo L, Job JC, New MI, eds. Growth disorders: the state of the art. New York. Raven Press; 91-98.
26. Despres J-P, Prud'homme D, Pouliot M-C, Tremblay A, Bouchard C. 1991 Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr. 54:471-477.
27. Rasmussen MH, Andersen T, Breum L, Gotzsche PC, Hilsted J. 1993 Cimetidine suspension as adjuvant to energy restricted diet in treating obesity. Br Med J. 306:1093-1096.
28. Rasmussen MH, Andersen T, Breum L, Hilsted J, Gotzsche PC. 1993 Observer variation in measurements of waist-hip ratio and the abdominal sagittal diameter. Int J Obesity. 17:323-327.
29. Kvist H, Chowdhury B, Grangard U, Tylen U, Sjostrom L. 1988 Total and visceral adipose-tissue volumes derived from measurements with computered tomography in adult men and women: predicitive equations. Am J Clin Nutr. 48:1351-1361.
30. Gotfredsen A, Hilsted J. 1994 Accuracy of body composition measurements by dual energy X-ray absorptiometry (DXA). Bone Miner. 25(Suppl 2):33.
31. Meriam GR, Watcher KW. 1982 Algorithms for the study of episodic hormone secretion Am J Physiol. 243:E310-E318.
32. Finkelstein JW, Roffwarg HP, Boyard RM, Kream J, Heilman L. 1972 Age-related changes in the 24-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab. 35:665-670.
33. Parker ML, Utiger RD, Daughaday WH. 1962 Studies on human growth hormone. 11. The physiological disposition and metabolic rate of human growth hormone in man. J Clin Invest. 41:262-268.
34. Glick SM, Roth J, Lonergan ET. 1964 Survival of endogenous human growth hormone in plasma. J Clin Endocrinol Metab. 24:501-505.
35. Refetoff S, Sonksen PH. 1970 Disappearance rate of endogenous and exogenous human growth hormone in man. J Clin Endocrinol Metab. 30:386-392.
36. Kuilboer MM, Kleijer B, Kamp GA, Veldhuis JD, Johnson JD, Wit J-M. 1992 Comparison of four computerized models to estimate 24-hour growth hormone secretion in girls with Turner's syndrome. Horm Res. 38:125-133.
37. Tapanien P, Knip M, Lautala P, Leppaluoto J. 1988 Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men. J Clin Endocrinol Metab. 67:845-849.
38. Zadik Z, Stuart AC, Gilula Z, Kowarski AA. 1990 Reproducibility of growth hormone testing procedures: a comparison between 24 h integrated concentration and pharmacological stimulation. J Clin Endocrinol Metab. 71:1127-1130.
39. Alba-Roth J, Muller OA, Schopohl J, von Werder K. 1988 Arginine stimulates growth hormone secretion by supressing endogenous somatostatin secretion. J Clin Endocrinol Metab. 67:1186-1189.
40. Cordido F, Diequez C, Casanueva FF. 1990 Effect of central cholinergic neurotransmission enhancement by pyridogstigmine on the growth hormone secretion elicted by clonidine, arginine, or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab 70:1361-1370.
41. Sukegawa I, Hizuka N, Tanako K, et al. 1988 Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion. J Clin Endocrinol Metab. 66:117-123.
42. Tannebaum GS, Guyda HJ, Posner BI. 1983 Insulin-like growth factors: a role in growth hormone negative feedback, and body weight regulation via brain. Science. 220:77-79.
43. Guler HP, Zapf J, Frosch ER. 1987 Short-term metabolic effects of recombinant human insulin-like growth factor 1 in healthy adults. N Engl J Med. 317:137-140.
44. Hartman ML, Clayton PE, Johnson ML, et al. 1993 A low-dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly supresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest 91:2453-2462.
45. Loche S, Cappa M, Borrelli P, et al. 1987 Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol (Oxf). 27:145-153.
46. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
47. Juul A, Pedersen SA, Sorensen S, et al. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3. Bone isoenzyme alkaline phosphatase and forearm bone mineral content in adults with GH-deficiency of childhood onset. Eur J Endocrinol. In press.
48. Weltman A, Weltman JY, Hartman ML, et al. 1994 Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab. 78:543-548.
49. Melmed S. 1984 Insulin supresses growth hormone by rat pituitary cells. J Clin Invest. 73:1425-1433.